☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
EMA
New Drug Designations - August 2024
September 25, 2024
Advancing Urothelial Carcinoma Care: Ahsan Arozullah from Astellas Pharma in an Exclusive Interview with PharmaShots
September 4, 2024
KalVista Reports the US FDA’s NDA Acceptance of Sebetralstat for Treating Hereditary Angioedema (HAE)
September 3, 2024
New Drug Designations - July 2024
August 27, 2024
Merck’s Winrevair (Sotatercept) Receives the EC’s Approval to Treat Pulmonary Arterial Hypertension (PAH)
August 26, 2024
Regeneron Showcases Updated on BLA for Linvoseltamab to Treat R/R Multiple Myeloma (MM)
August 21, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.